Department of Anesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta Specializzazione), Palermo, Italy.
Maastricht University, Maastricht, The Netherlands.
Crit Care. 2019 Jul 30;23(1):266. doi: 10.1186/s13054-019-2541-3.
Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) is an increasingly adopted life-saving mechanical circulatory support for a number of potentially reversible or treatable cardiac diseases. It is also started as a bridge-to-transplantation/ventricular assist device in the case of unrecoverable cardiac or cardio-respiratory illness. In recent years, principally for non-post-cardiotomy shock, peripheral cannulation using the femoral vessels has been the approach of choice because it does not need the chest opening, can be quickly established, can be applied percutaneously, and is less likely to cause bleeding and infections than central cannulation. Peripheral ECMO, however, is characterized by a higher rate of vascular complications. The mechanisms of such adverse events are often multifactorial, including suboptimal arterial perfusion and hemodynamic instability due to the underlying disease, peripheral vascular disease, and placement of cannulas that nearly occlude the vessel. The effect of femoral artery damage and/or significant reduced limb perfusion can be devastating because limb ischemia can lead to compartment syndrome, requiring fasciotomy and, occasionally, even limb amputation, thereby negatively impacting hospital stay, long-term functional outcomes, and survival. Data on this topic are highly fragmentary, and there are no clear-cut recommendations. Accordingly, the strategies adopted to cope with this complication vary a great deal, ranging from preventive placement of antegrade distal perfusion cannulas to rescue interventions and vascular surgery after the complication has manifested.This review aims to provide a comprehensive overview of limb ischemia during femoral cannulation for VA-ECMO in adults, focusing on incidence, tools for early diagnosis, risk factors, and preventive and treating strategies.
静脉-动脉体外膜肺氧合(V-A ECMO)是一种越来越被采用的生命支持机械循环,用于多种潜在可逆转或可治疗的心脏疾病。在不可逆转的心脏或心肺疾病的情况下,它也被用作移植/心室辅助装置的桥接。近年来,主要用于非心脏手术后休克,使用股血管的外周插管已成为首选方法,因为它不需要开胸,可以快速建立,可以经皮应用,并且比中心插管引起出血和感染的可能性更小。然而,外周 ECMO 的特点是血管并发症发生率较高。这些不良事件的机制通常是多因素的,包括由于基础疾病、外周血管疾病和几乎阻塞血管的插管导致的动脉灌注不足和血流动力学不稳定。股动脉损伤和/或显著减少肢体灌注的影响可能是毁灭性的,因为肢体缺血可导致间隔综合征,需要切开筋膜,偶尔甚至需要截肢,从而对住院时间、长期功能结果和生存产生负面影响。关于这个主题的数据非常零散,没有明确的建议。因此,应对这种并发症的策略差异很大,从预防性放置顺行远端灌注插管到并发症出现后的抢救干预和血管手术。
本篇综述旨在全面概述成人 V-A ECMO 股动脉插管期间的肢体缺血,重点介绍发病率、早期诊断工具、危险因素以及预防和治疗策略。